The risks of in-hospital complications and mortality at 30 days were significantly higher in patients with severe aortic ...

What follows is an outsider's report on the next big phase of cardiology—the percutaneous treatment of valvular heart disease. I have little doubt that in 5 to 10 years, transcutaneous valves will be ...

The incidence of implantation of a permanent pacemaker immediately after transcatheter aortic valve implantation (TAVI) increased significantly over a period of 6 years in Spain, and this rising trend ...

Transcatheter aortic valve implantation (TAVI) was superior to surgical aortic valve replacement for reducing death, stroke or rehospitalization in women with severe aortic stenosis, according to late ...

One medtech company is combining the power of artificial intelligence with transcatheter aortic valve implantation (TAVI) procedures. Caranx Medical said it filed for FDA submission for TAVIPILOT Soft ...

Eight-year data from the NOTION trial again show no differences in clinical outcomes and bioprosthetic valve failure between TAVI and surgery among patients at low surgical risk, suggesting good ...

People who underwent a minimally invasive procedure to have their heart's aortic valve replaced had similar health outcomes years after treatment as people who had surgery, Cedars-Sinai investigators ...

Valvular heart disease affects about 25 million people in China and 100 million worldwide every year. Nearly 50% suffer from conditions in aortic valve — the main outflow valve from the heart. Without ...

Ed Fulcher, 90, a lifelong resident of Morehead City, works every day in his home shop building model boats for sale. About a year ago, Fulcher noticed he couldn’t work in his shop more than 15 ...